"Pershing Touts More Investor Support for Allergan Special Meeting," published at 8:40 a.m. EDT, incorrectly said BMO Capital Markets analyst David Maris has said that he thinks Valeant and Pershing have a 50% to 60% chance of taking over Allergan. Rather, BMO Capital Markets analyst Alex Arfaei said that. Mr. Maris, meanwhile, said he believes there is less than a 50% chance of the deal getting done.

Subscribe to WSJ: http://online.wsj.com?mod=djnwires

Allergan (NYSE:AGN)
Historical Stock Chart
From Mar 2024 to Apr 2024 Click Here for more Allergan Charts.
Allergan (NYSE:AGN)
Historical Stock Chart
From Apr 2023 to Apr 2024 Click Here for more Allergan Charts.